The story · written by gpt-6,
Patients in Seychelles could apply for approval to obtain prescribed CBD medicines under rules that took effect on 1 July 2020. Access depended on a specialist’s assessment and a permit from the Public Health Authority. The permitted products were tightly defined, while smoking and growing cannabis remained prohibited.
A family’s court case preceded the rules
The 2016 drug law allowed controlled drugs to be used medically under regulations. Ralph Volcere challenged the absence of new rules while seeking access for his mother, who had Alzheimer’s disease.
In May 2019 the Constitutional Court ordered ministers to issue regulations within twenty-four months, leaving their content to the government. Home Affairs Minister Macsuzy Mondon made the CBD rules the following February, in consultation with the minister responsible for health.
Only defined CBD medicines qualified
The regulations covered products made from cannabidiol, including edible preparations, ointments and tinctures intended for use without smoking. Their definition excluded forms of cannabis producing a psychoactive effect.
THC and the related substances specified in the rules could together amount to no more than two per cent of the CBD content. The two-per-cent limit was measured against the amount of CBD in the product.
The Health Care Agency could import medicines for its pharmacies or authorised pharmacies. Other importers needed a licence. Patients, including qualifying visitors, needed prior written permission to enter or leave Seychelles with the medicine.
Approval came before a prescription
A specialist had to assess the patient and conclude that earlier prescribed treatments had been ineffective, that CBD medicine might help, and that likely benefits outweighed the risks. The application also required a plan for continued care.
The Public Health Authority reviewed the certification with the Medical and Dental Council. Approval led to confidential registration and a permit, followed by a prescription. Pharmacies could dispense no more than a thirty-day supply at a time.
The rules allowed designated caregivers to obtain and administer medicine for a patient. They also provided extra consent and approval requirements for children.
Patients still faced strict boundaries
Using the medicine without authorisation could bring a fine of up to 10,000 rupees, up to six months in prison, or both. The regulations expressly prohibited cultivating or smoking any form of cannabis and allowed police to arrest suspects without a warrant.
In January 2023, the Seychelles Kanabis Association criticised the rules as unfit for patients’ needs, linking difficulties obtaining treatment to the risk of criminal punishment. Its intervention kept patient access part of the wider cannabis-law debate in Seychelles.[1][2][3]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%2 → 2
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Seychelles's current scores.
References
- Seychelles Official Gazette — Cannabidiol-based Products for Medical Purposes Regulations 2020, S.I. 25Complete Regulations 1–20 and Schedule 1; gazette pp. 165–186archived
- Seychelles Constitutional Court — Volcere v Minister for Home Affairs and others, signed judgment, 31 May 2019Majority paragraphs 1–46, especially 13, 24–32, 40–46; signed/delivered 31 May despite catalogue date 30 Mayarchived
- Seychelles Nation — Seychelles Kanabis Association decries sentencing for cannabis-related offences, 30 January 2023archived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.